-
MDA Ambassador Guest Blog: What the Disability Movement Means to Me
Callie Hall lives in Orlando Florida and lives with a unique neuromuscular disability. She is passionate about disability rights, bluegrass mandolin, and being outdoors. RIIIIIIIING the school bell signals the end of the class period. My teacher says, “Alright everyone, we have finished our week of learning about all the Civil Rights Movements.” Chairs shift…
-
FDA set to decide on experimental DMD treatment in early 2027
The U.S. Food and Drug Administration (FDA) is considering whether to conditionally approve zeleciment rostudirsen (z-rostudirsen), an experimental therapy for Duchenne muscular dystrophy (DMD) in patients with mutations that are amenable to exon 51 skipping. Z-rostudirsen developer Dyne Therapeutics announced that the FDA has agreed to review an application seeking accelerated approval of the investigational…








